AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7956275 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (gauze, conventional polyurethane, highly permeable polyurethane)
Number of subjects: 442
Study 3679573 — intervention group
Group type: EXPERIMENTAL
Intervention: Single donor plasma in therapeutic plasma exchange (TPE)
Number of subjects: 37
Study 3679573 — intervention group
Group type: COMPARATOR
Intervention: Random plasma in therapeutic plasma exchange (TPE)
Number of subjects: 37
Study 29542008 — intervention group
Group type: EXPERIMENTAL
Intervention: Safinamide
Number of subjects: 0
Study 29542008 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24609848 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational seminar on biospecimen collection
Number of subjects: 395
Study 22445730 — intervention group
Group type: EXPERIMENTAL
Intervention: White coat
Number of subjects: 143
Study 22445730 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional dress
Number of subjects: 143
Study 22445730 — intervention group
Group type: COMPARATOR
Intervention: Casual
Number of subjects: 143
Study 22445730 — intervention group
Group type: COMPARATOR
Intervention: Suit
Number of subjects: 143
Study 20056199 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate treatment
Number of subjects: 0
Study 20056199 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19065891 — intervention group
Group type: EXPERIMENTAL
Intervention: WM plus DCHD
Number of subjects: 36
Study 19065891 — intervention group
Group type: COMPARATOR
Intervention: WM
Number of subjects: 36
Study 19065891 — intervention group
Group type: COMPARATOR
Intervention: WM plus placebo
Number of subjects: 36
Study 15973099 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous ethanol injection therapy
Number of subjects: 76
Study 15973099 — intervention group
Group type: COMPARATOR
Intervention: Surgical resection
Number of subjects: 76
Study 12792453 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard education
Number of subjects: 40
Study 12792453 — intervention group
Group type: COMPARATOR
Intervention: Experimental educational intervention
Number of subjects: 40
Study 10235449 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotoxin (4 ng/kg)
Number of subjects: 30
Study 10235449 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (1000 mg po)
Number of subjects: 30
Study 10235449 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 30
Study 7476241 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonological working memory intervention
Number of subjects: 0
Study 7476241 — intervention group
Group type: EXPERIMENTAL
Intervention: Visuospatial working memory intervention
Number of subjects: 0
Study 7476241 — intervention group
Group type: EXPERIMENTAL
Intervention: Pursuit rotor and memory tasks (prior practice)
Number of subjects: 0
Study 7476241 — intervention group
Group type: EXPERIMENTAL
Intervention: Random-number generation task
Number of subjects: 0
Study 2156945 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical high-dose interferon-alpha (10(6) IU/g with 1% nonoxynol-9 in 3.5% methylcellulose) applied three times daily for 5 days
Number of subjects: 188
Study 2156945 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical low-dose interferon-alpha (10(3) IU/g with 0.1% nonoxynol-9 in 3.5% methylcellulose) applied three times daily for 5 days
Number of subjects: 188
Study 2156945 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3.5% methylcellulose, alone) applied three times daily for 5 days
Number of subjects: 188
Study 2156945 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical high-dose interferon-alpha
Number of subjects: 188
Study 2156945 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188
Study 396086 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol 150 mg/day
Number of subjects: 24
Study 396086 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol 300 mg/day
Number of subjects: 24
Study 396086 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol 600 mg/day
Number of subjects: 24
Study 396086 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol 900 mg/day
Number of subjects: 24
Study 396086 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol (all doses)
Number of subjects: 24
Study 31079189 — intervention group
Group type: COMPARATOR
Intervention: Immediate combination therapy (tamsulosin-dutasteride)
Number of subjects: 10238
Study 31079189 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed combination therapy (switching from tamsulosin monotherapy after 6 months)
Number of subjects: 10238
Study 31079189 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed combination therapy (switching from tamsulosin monotherapy after 12 months)
Number of subjects: 10238
Study 31079189 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed combination therapy (switching from tamsulosin monotherapy after 24 months)
Number of subjects: 10238
Study 30428445 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) for panic disorder with agoraphobia (PD/AG)
Number of subjects: 42
Study 28842165 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Kidney Disease (Stages 1-3)
Number of subjects: 12174
Study 26494524 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged-release oxycodone-naloxone (OXN PR) 5 mg oxycodone and 25 mg naloxone, twice daily for 16 weeks
Number of subjects: 202
Study 26494524 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study 26494524 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged-release oxycodone-naloxone (OXN PR)
Number of subjects: 202
Study 24364618 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (0.6 mg)
Number of subjects: 87
Study 24364618 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose alcohol (male: 0.3g/kg; female: 0.27g/kg)
Number of subjects: 87
Study 24364618 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (0.6 mg) and Low-dose alcohol (male: 0.3g/kg; female: 0.27g/kg)
Number of subjects: 87
Study 21109748 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific IgG4 testing against foods
Number of subjects: 73
Study 21109748 — intervention group
Group type: COMPARATOR
Intervention: Double-blind placebo-controlled food challenge
Number of subjects: 73
Study 19737321 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal therapy with far-infrared rays at 40 degrees C for 15 minutes once a day on two days a week for a total of 18 sessions
Number of subjects: 41
Study 19737321 — intervention group
Group type: COMPARATOR
Intervention: Control group received a plain adhesive patch placed on the same acupoint
Number of subjects: 41
Study 16670409 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone plus medical management (100 mg/d)
Number of subjects: 1383
Study 16670409 — intervention group
Group type: EXPERIMENTAL
Intervention: CBI plus medical management and placebos
Number of subjects: 1383
Study 16670409 — intervention group
Group type: EXPERIMENTAL
Intervention: Both naltrexone and CBI plus medical management
Number of subjects: 1383
Study 16670409 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 1383
Study 16670409 — intervention group
Group type: EXPERIMENTAL
Intervention: CBI without pills or medical management
Number of subjects: 1383
Study 16670409 — intervention group
Group type: EXPERIMENTAL
Intervention: Acamprosate
Number of subjects: 1383
Study 16670409 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus medical management
Number of subjects: 1383
Study 15543092 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA testing as a serum tumor marker for early detection and monitoring of treatment response.
Number of subjects: 0
Study 15543092 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxane-based regimens in phase 3 randomized controlled trials.
Number of subjects: 0
Study 15543092 — intervention group
Group type: EXPERIMENTAL
Intervention: Agents such as selenium and vitamin E in chemoprevention trials.
Number of subjects: 0
Study 11500333 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive smoking cessation program (SI)
Number of subjects: 5887
Study 11500333 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 5887
Study 11500333 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained quitters
Number of subjects: 5887
Study 11500333 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers with LRI
Number of subjects: 5887
Study 11500333 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers averaging one LRI/yr over 5 years
Number of subjects: 5887
Study 11500333 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers with more than one LRI/yr
Number of subjects: 5887
Study 11500333 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic bronchitis
Number of subjects: 5887
Study 11500333 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking and LRI interaction
Number of subjects: 5887
Study 9640015 — intervention group
Group type: EXPERIMENTAL
Intervention: Pattern stimulation
Number of subjects: 48
Study 9640015 — intervention group
Group type: EXPERIMENTAL
Intervention: Flash stimulation
Number of subjects: 48
Study 9640015 — intervention group
Group type: EXPERIMENTAL
Intervention: Arteriosclerosis optic nerve atrophy
Number of subjects: 48
Study 9640015 — intervention group
Group type: EXPERIMENTAL
Intervention: Toxic neuropathy optic nerve atrophy
Number of subjects: 48
Study 7943490 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal invitation letter with appointment time
Number of subjects: 2266
Study 7943490 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal invitation letter without appointment time
Number of subjects: 2266
Study 7943490 — intervention group
Group type: EXPERIMENTAL
Intervention: Second letter to nonattenders
Number of subjects: 2266
Study 7943490 — intervention group
Group type: COMPARATOR
Intervention: Distance from the program
Number of subjects: 2266
Study 7943490 — intervention group
Group type: COMPARATOR
Intervention: Percentage of non-English speaking women in a neighborhood
Number of subjects: 2266
Study 7943490 — intervention group
Group type: COMPARATOR
Intervention: Socioeconomic status of areas
Number of subjects: 2266
Study 3128320 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocolloid dressing (Granuflex)
Number of subjects: 0
Study 3128320 — intervention group
Group type: COMPARATOR
Intervention: Paraffin gauze dressing (Jelonet)
Number of subjects: 0
Study 30550208 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoiding allergic plant foods intake (Group A)
Number of subjects: 40
Study 30550208 — intervention group
Group type: COMPARATOR
Intervention: No avoidance of allergic plant foods (Group B)
Number of subjects: 40
Study 28444964 — intervention group
Group type: EXPERIMENTAL
Intervention: Landiolol hydrochloride
Number of subjects: 100
Study 28444964 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 25658223 — intervention group
Group type: EXPERIMENTAL
Intervention: Active promotional strategies (face-to-face offers and telephone calls)
Number of subjects: 30
Study 25658223 — intervention group
Group type: COMPARATOR
Intervention: Passive promotional strategies (letters and bag stuffers)
Number of subjects: 30
Study 23553478 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbidopa (average daily dose of 480 mg, range 325-600 mg/day)
Number of subjects: 12
Study 23553478 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 23553478 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbidopa
Number of subjects: 12
Study 21180676 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk supplemented with Lactobacillus rhamnosus LB21 (107 CFU/ml)
Number of subjects: 18
Study 21180676 — intervention group
Group type: COMPARATOR
Intervention: Standard control milk (placebo)
Number of subjects: 18
Study 18202961 — intervention group
Group type: EXPERIMENTAL
Intervention: EP + A (n = 31): CEE 0.625 mg plus MPA 2.5 mg and methyltestosterone 2.0 mg
Number of subjects: 60
Study 18202961 — intervention group
Group type: COMPARATOR
Intervention: EP (n = 29): CEE 0.625 mg plus MPA 2.5 mg and placebo
Number of subjects: 60
Study 16395548 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg acetylsalicylic acid (ASA)
Number of subjects: 317
Study 16395548 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group (no medication)
Number of subjects: 317
Study 12728160 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung volume reduction surgery (LVRS)
Number of subjects: 55
Study 12728160 — intervention group
Group type: COMPARATOR
Intervention: Control group (medical management)
Number of subjects: 55
Study 10810433 — intervention group
Group type: EXPERIMENTAL
Intervention: Medroxyprogesteroneacetate (MPA)
Number of subjects: 163
Study 10810433 — intervention group
Group type: COMPARATOR
Intervention: CAF adjuvant chemotherapy
Number of subjects: 163
Study 10810433 — intervention group
Group type: EXPERIMENTAL
Intervention: Bcl-2 and p53 expression
Number of subjects: 163
Study 10810433 — intervention group
Group type: EXPERIMENTAL
Intervention: MIB-1
Number of subjects: 163
Study 9238878 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental rinse containing 2.18% aluminum lactate
Number of subjects: 56
Study 9238878 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control dental rinse
Number of subjects: 56
Study 1459529 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA (0.24g per kg body weight)
Number of subjects: 49
Study 1459529 — intervention group
Group type: COMPARATOR
Intervention: Casein (equinitrogenous amount)
Number of subjects: 49
Study 1459529 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA
Number of subjects: 49
Study 1459529 — intervention group
Group type: COMPARATOR
Intervention: Casein
Number of subjects: 49
Study 6506819 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval run exercise therapy for untreated patients
Number of subjects: 2
Study 6506819 — intervention group
Group type: COMPARATOR
Intervention: Interval run exercise therapy for propranolol-treated patients
Number of subjects: 2
Study 30126775 — intervention group
Group type: EXPERIMENTAL
Intervention: Cementless bone preserving stem (Fitmore)
Number of subjects: 140
Study 30126775 — intervention group
Group type: COMPARATOR
Intervention: Cementless straight stem (CLS Spotorno)
Number of subjects: 140
Study 29587159 — intervention group
Group type: EXPERIMENTAL
Intervention: MEmory Specificity Training (MEST)
Number of subjects: 62
Study 29587159 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation and Supportive Counselling (PSC)
Number of subjects: 62
Study 26278704 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated group (Group 1) using target-controlled infusion system (Veryark‐CLMRIS‐I‐China)
Number of subjects: 0
Study 26278704 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group 2) using routinely used acceleromyography device (TOF Watch SX)
Number of subjects: 0
Study 26278704 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study 26278704 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 0
Study 22397516 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep peeling using phenol
Number of subjects: 24
Study 22397516 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous collagen induction combined with TCA 20%
Number of subjects: 24
Study 22240619 — intervention group
Group type: EXPERIMENTAL
Intervention: AnaConDa
Number of subjects: 30
Study 22240619 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study 20187281 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory muscle endurance training (RMT)
Number of subjects: 18
Study 20187281 — intervention group
Group type: COMPARATOR
Intervention: Control training (CON)
Number of subjects: 18
Study 17937851 — intervention group
Group type: EXPERIMENTAL
Intervention: Forlax (20 g/d)
Number of subjects: 216
Study 17937851 — intervention group
Group type: COMPARATOR
Intervention: Lactulose (15 mL/d)
Number of subjects: 216
Study 14693984 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Anodyne Therapy System (ATS) treatment
Number of subjects: 27
Study 14693984 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 27
Study 12511184 — intervention group
Group type: COMPARATOR
Intervention: Diabetes Type 2
Number of subjects: 52
Study 12511184 — intervention group
Group type: COMPARATOR
Intervention: Diabetes Type 1
Number of subjects: 52
Study 12511184 — intervention group
Group type: COMPARATOR
Intervention: Both types of DM
Number of subjects: 52
Study 9689294 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective creams (3 different creams)
Number of subjects: 15
Study 9689294 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective creams (1 product)
Number of subjects: 15
Study 9689294 — intervention group
Group type: COMPARATOR
Intervention: Petrolatum (control)
Number of subjects: 15
Study 7858795 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam splints
Number of subjects: 41
Study 7858795 — intervention group
Group type: EXPERIMENTAL
Intervention: Eggshell foam
Number of subjects: 41
Study 7858795 — intervention group
Group type: COMPARATOR
Intervention: Duoderm
Number of subjects: 41
Study 7858795 — intervention group
Group type: COMPARATOR
Intervention: Heel protector boots
Number of subjects: 41
Study 2570700 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg diprafenone
Number of subjects: 0
Study 2570700 — intervention group
Group type: COMPARATOR
Intervention: 40 mg propranolol
Number of subjects: 0
Study 2570700 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29579327 — intervention group
Group type: EXPERIMENTAL
Intervention: Trends in carcinoembryonic antigen (CEA) measurements
Number of subjects: 0
Study 29579327 — intervention group
Group type: COMPARATOR
Intervention: Single CEA measurements
Number of subjects: 0
Study 29579327 — intervention group
Group type: EXPERIMENTAL
Intervention: Trends in CEA measurements
Number of subjects: 0
Study 28213365 — intervention group
Group type: EXPERIMENTAL
Intervention: TAS-102 35 mg/m2 orally twice daily after meals on days 1 through 5 and 8 through 12 of each 28‐day cycle (n = 534)
Number of subjects: 800
Study 28213365 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo (n = 266)
Number of subjects: 800
Study 28213365 — intervention group
Group type: EXPERIMENTAL
Intervention: TAS-102
Number of subjects: 800
Study 26453484 — intervention group
Group type: EXPERIMENTAL
Intervention: High-motivating positive affect (interest)
Number of subjects: 155
Study 26453484 — intervention group
Group type: COMPARATOR
Intervention: Low-motivating positive affect (serenity)
Number of subjects: 155
Study 26453484 — intervention group
Group type: EXPERIMENTAL
Intervention: High-motivating negative affect (disgust)
Number of subjects: 155
Study 26453484 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-motivating negative affect (anxiety)
Number of subjects: 155
Study 26453484 — intervention group
Group type: COMPARATOR
Intervention: Neutral state
Number of subjects: 155
Study 23196118 — intervention group
Group type: EXPERIMENTAL
Intervention: Nissen fundoplication
Number of subjects: 20
Study 23196118 — intervention group
Group type: COMPARATOR
Intervention: Non-Nissen fundoplication
Number of subjects: 20
Study 21672344 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (n = 46)
Number of subjects: 86
Study 21672344 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 40)
Number of subjects: 86
Study 19485581 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 57
Study 19485581 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 57
Study 17267379 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 51
Study 17267379 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 51
Study 12897995 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous morphine (10 micro g/kg per hour)
Number of subjects: 68
Study 12897995 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent morphine (30 micro g/kg per 3 hours)
Number of subjects: 68
Study 12897995 — intervention group
Group type: COMPARATOR
Intervention: Mechanical ventilation
Number of subjects: 68
Study 12897995 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous morphine and Intermittent morphine
Number of subjects: 68
Study 10736078 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane 6% end-tidal
Number of subjects: 47
Study 10736078 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl 10 microg.kg‐1 bolus i.v. with an infusion of 3 microg.kg‐1.h‐1
Number of subjects: 47
Study 8932966 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR) therapy with eye movement
Number of subjects: 17
Study 8932966 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR) therapy without eye movement (eyes-fixed)
Number of subjects: 17
Study 8932966 — intervention group
Group type: COMPARATOR
Intervention: Imaginal flooding (previous study for comparison)
Number of subjects: 17
Study 1416894 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil 400 mg orally per day for 10 days
Number of subjects: 18
Study 1416894 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefixime 400 mg orally per day for 10 days
Number of subjects: 18
Study 1416894 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 3927068 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilation group (10 breaths/min with 100% oxygen at a tidal volume of 10 ml/kg)
Number of subjects: 20
Study 3927068 — intervention group
Group type: COMPARATOR
Intervention: Nonventilation group (apneic oxygenation at zero end-expiratory pressure)
Number of subjects: 20
Study 28575321 — intervention group
Group type: EXPERIMENTAL
Intervention: PANSS-6
Number of subjects: 577
Study 28575321 — intervention group
Group type: EXPERIMENTAL
Intervention: PANSS-30
Number of subjects: 577
Study 28575321 — intervention group
Group type: EXPERIMENTAL
Intervention: PANSS-6 and PANSS-30
Number of subjects: 577
Study 26909888 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (60 min, 2 times/week for 12 weeks)
Number of subjects: 61
Study 26909888 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 61
Study 22389940 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory-enhanced hatha yoga (3 weeks, ≥9 sessions)
Number of subjects: 70
Study 22389940 — intervention group
Group type: COMPARATOR
Intervention: Control (no yoga)
Number of subjects: 70